Abstract
INTRODUCTION
Percutaneous kidney biopsy is a safe method widely used in the diagnosis and management of renal diseases. The aim of our study is to evaluate the factors associated with the risk of bleeding associated with the procedure in imaging-guided percutaneous kidney biopsies.
METHODS
Patients who were referred to our interventional radiology clinic between May 2018 and December 2019 and who underwent ultrasound-guided percutaneous kidney biopsy were retrospectively scanned. Patients above 18 years old who had pre-procedure ultrasound imaging and post-procedure pathology information were included in the study. Pediatric patients under 18 years old and transplanted kidney biopsies were excluded.
RESULTS
A total of 107 patients were included in the study. 57 of the patients were male (53.3%) and 50 were female (46.7%). The mean age of the patients was 47.8 ± 15.5. The mean Hb value of the patients before the procedure was 11.2 ± 1.7 mg / dl, while the mean Hb value after the procedure was 11.1 ± 1.7 mg / dl. The median Hb drop in patients was 4.2%. In statistical analysis, there was no significant difference between hemoglobin values before and after the procedure (p = 0.864). No significant correlation was found between the decrease in hemoglobin values and patient age (p = 0.406), kidney size (p = 0.814), parenchymal echogenicity (p = 0,175) and parenchymal thickness (p = 0,254).
DISCUSSION AND CONCLUSION
Ultrasound-guided percutaneous kidney biopsy is a method that can be used safely in the diagnosis of kidney diseases. Although there is a risk of bleeding, this risk is minimal with appropriate evaluation before the procedure.